miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression (Q38972595)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q37829209)
(Q56107640)
(Q102061189)
(P304) 1320-1334
(P407) (Q1860)
(P433) 13
(P478) 74
(P577) Tuesday, July 22, 2014
(P921) (Q864574)
(Q181257)
(Q420436)
(P1433) (Q7758608)
(P1476) "miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression" (language: en)
(P2860) (Q34577447)
(Q34151121)
(Q37721016)
(Q36309722)
(Q37034313)
(Q34516014)
(Q35462077)
(Q37808080)
(Q21144238)
(Q27860960)
(Q29614235)
(Q28484310)
(Q39186608)
(Q33606225)
(Q34742648)
(Q36100258)
(Q39812809)
(Q39478533)
(Q42965349)
(Q34186822)
(Q29547765)
(Q39478502)
(Q28032481)
(Q27860962)
(Q37751868)
(Q29614237)
(Q24614672)
(Q21144210)
(Q33728084)
(Q24300024)
(Q42055882)
(Q39429436)
(Q39712751)
(Q39658971)
(Q34094556)
(Q39461411)
(Q39605990)
(Q21134916)
(Q24617130)
(Q39932777)
(Q39576802)
(Q39518813)
(Q42945633)
(Q35678607)
(Q39465507)
(Q34722558)
(Q33576922)
(Q29398839)
(Q34202479)
(Q39456571)
(Q34914565)
(Q45787161)
(Q46799300)
(Q46983189)
(Q39583239)
other details
description scientific article

External Links